182 related articles for article (PubMed ID: 25486950)
1. Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
Shah N; Rezvani K; Hosing C; Kebriaei P; Wierda W; Cooper L; Shpall E
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl(Suppl):S18-22. PubMed ID: 25486950
[TBL] [Abstract][Full Text] [Related]
2. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
Singh N; Frey NV; Grupp SA; Maude SL
Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
[TBL] [Abstract][Full Text] [Related]
3. Advances in CAR T-cell therapy for chronic lymphocytic leukemia.
Porter DL
Clin Adv Hematol Oncol; 2018 Feb; 16(2):118-120. PubMed ID: 29741512
[No Abstract] [Full Text] [Related]
4. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
5. Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.
Fraietta JA; Schwab RD; Maus MV
Semin Oncol; 2016 Apr; 43(2):291-9. PubMed ID: 27040708
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review.
Mato AR; Thompson MC; Nabhan C; Svoboda J; Schuster SJ
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):852-856. PubMed ID: 28826693
[TBL] [Abstract][Full Text] [Related]
7. Are chimeric antigen receptor T cells ready for prime time?
Brentjens RJ
Clin Adv Hematol Oncol; 2016 Jan; 14(1):17-9. PubMed ID: 27057662
[No Abstract] [Full Text] [Related]
8. Chimeric antigen receptor T cell therapy: 25years in the making.
Gill S; Maus MV; Porter DL
Blood Rev; 2016 May; 30(3):157-67. PubMed ID: 26574053
[TBL] [Abstract][Full Text] [Related]
9. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
Houot R; Schultz LM; Marabelle A; Kohrt H
Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
[TBL] [Abstract][Full Text] [Related]
10. CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era.
Hay KA; Turtle CJ
Immunotherapy; 2018 Feb; 10(4):251-254. PubMed ID: 29421980
[No Abstract] [Full Text] [Related]
11. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
Hochberg J; El-Mallawany NK; Cairo MS
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
[TBL] [Abstract][Full Text] [Related]
13. Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications.
Riches JC; Gribben JG
Hematol Oncol Clin North Am; 2013 Apr; 27(2):207-35. PubMed ID: 23561470
[TBL] [Abstract][Full Text] [Related]
14. Prospects of chimeric antigen receptor T-cell and natural killer cell therapies in acute leukemias.
Khan M; Mansoor AE; Olson AL
Future Oncol; 2016 Oct; 12(19):2179-82. PubMed ID: 27250512
[No Abstract] [Full Text] [Related]
15. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Sportoletti P; De Falco F; Del Papa B; Baldoni S; Guarente V; Marra A; Dorillo E; Rompietti C; Adamo FM; Ruggeri L; Di Ianni M; Rosati E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206399
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic approaches using genetically modified cells].
Anliker B; Renner M; Schweizer M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1274-80. PubMed ID: 26349563
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution in chronic lymphocytic leukemia.
Riches JC; Ramsay AG; Gribben JG
Curr Hematol Malig Rep; 2012 Mar; 7(1):13-20. PubMed ID: 22231031
[TBL] [Abstract][Full Text] [Related]
18. Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?
Katz OB; Yehudai-Ofir D; Zuckerman T
Acta Haematol; 2024; 147(1):99-112. PubMed ID: 37812926
[TBL] [Abstract][Full Text] [Related]
19. Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia.
Riches JC; Gribben JG
Discov Med; 2013 Dec; 16(90):295-302. PubMed ID: 24333409
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.
Brower V
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
